Mechanism of temporal gradients in shear-induced ERK1/2 activation and proliferation in endothelial cells

被引:64
|
作者
Bao, XP [1 ]
Lu, CY [1 ]
Frangos, JA [1 ]
机构
[1] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA
关键词
fluid shear; mechanotransduction; endothelial proliferation; flow;
D O I
10.1152/ajpheart.2001.281.1.H22
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the current study was to investigate the intracellular signaling cascade that leads to temporal gradients in shear (TGS) induced endothelial cell proliferation, with a focus on the involvement of extracellular signal-regulated kinases 1 and 2 (ERK1/2). With the use of well-defined pulsatile, impulse, step, and ramp laminar flow profiles, we found that TGS (impulse flow and pulsatile flow) induced an enhanced and sustained (>30 min) phosphorylation of ERK1/2 relative to step flow (which contains a step increase in shear followed by steady shear), whereas steady shear (ramp flow) alone downregulated activated ERK1/2. Nitric oxide (NO) was found to mediate both the stimulatory effect of TGS and the inhibitory effect of steady shear on endothelial ERK1/2 phosphorylation. Reactive oxygen species (ROS) were also demonstrated to be associated with TGS-induced ERK1/2 phosphorylation. Both G(q/11) and G(i3) were necessary for the activation of ERK1/2 by TGS. Finally, the TGS-induced endothelial proliferative response was abolished by ERK1/2 inhibition. Our study demonstrated the essential role of G proteins, NO, and ROS in TGS-dependent ERK1/2 activation and proliferative response in vascular endothelial cells.
引用
收藏
页码:H22 / H29
页数:8
相关论文
共 50 条
  • [31] PKC-epsilon is required for mechano-sensitive activation of ERK1/2 in endothelial cells
    Traub, O
    Monia, BP
    Dean, NM
    Berk, BC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (50) : 31251 - 31257
  • [32] Fluvastatin attenuates IGF-1-induced ERK1/2 activation and cell proliferation by mevalonic acid depletion in human mesangial cells
    Shibata, Tatsuya
    Tamura, Masahito
    Kabashima, Narutoshi
    Serino, Ryota
    Tokunaga, Masaki
    Matsumoto, Mika
    Miyamoto, Tetsu
    Miyazaki, Mieko
    Furuno, Yumi
    Takeuchi, Masaaki
    Abe, Haruhiko
    Okazaki, Masahiro
    Otsuji, Yutaka
    LIFE SCIENCES, 2009, 84 (21-22) : 725 - 731
  • [33] Shear-induced changes in endothelin-1 secretion of microvascular endothelial cells
    Wang, GX
    Cai, SX
    Wang, PQ
    Ouyang, KQ
    Wang, YL
    Xu, SR
    MICROVASCULAR RESEARCH, 2002, 63 (02) : 209 - 217
  • [34] Low shear stress release procoagulant endothelial microparticles by a RhoK and ERK1/2-MAPK-dependent mechanism
    Vion, Anne-Clemence
    Ramkhelawon, Bhama
    Tedgui, Alain
    Lehoux, Stephanie
    Boulanger, Chantal M.
    VASCULAR PHARMACOLOGY, 2012, 56 (5-6) : 319 - 319
  • [35] Activation of ERK1/ERK2 phosphorylation by ATP in bovine chromaffin cells
    Hexum, Terry
    Luke, Toni
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 406 - 406
  • [36] Berberine Inhibits Endothelial Cell Proliferation via Repressing ERK1/2 Pathway
    Wen, Xiaoqing
    Zhou, Xia
    Guo, Ling
    NATURAL PRODUCT COMMUNICATIONS, 2023, 18 (03)
  • [37] The chemokine SDF1 alpha induces glioblastoma cells proliferation through the activation of ERK1/2 pathway
    Barbero, S
    Bajetto, A
    Bonavia, R
    Pirani, P
    Florio, T
    Schettini, G
    GLIA, 2002, : S30 - S30
  • [38] Proliferation of pancreatic B cells is inhibited by somatostatin SST2 receptors via a mechanism involving SAPK activation and the dephosphorylation of ERK1/2
    Smith, PA
    Sellers, LA
    Humphrey, PPA
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 : U138 - U138
  • [39] TRAIL induces proliferation of human glioma cells by c-FLIPL-mediated activation of ERK1/2
    Vilimanovich, U.
    Bumbasirevic, V.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2008, 65 (05) : 814 - 826
  • [40] β-adrenergic receptor activation promotes the proliferation of HepG2 cells via the ERK1/2/CREB pathways
    Lin, Xingcheng
    He, Jingjing
    Liu, Fuhong
    Li, Lehui
    Sun, Longhua
    Niu, Liyan
    Xi, Haolin
    Zhan, Yuan
    Liu, Xiaohua
    Hu, Ping
    ONCOLOGY LETTERS, 2023, 26 (06)